CLASSYS (A214150) Stock Overview
Provides medical aesthetics devices worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A214150 from our risk checks.
A214150 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
CLASSYS Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩49,250.00 |
| 52 Week High | ₩74,400.00 |
| 52 Week Low | ₩40,000.00 |
| Beta | 0.61 |
| 1 Month Change | -5.83% |
| 3 Month Change | -17.37% |
| 1 Year Change | -10.94% |
| 3 Year Change | 226.16% |
| 5 Year Change | 224.01% |
| Change since IPO | 967.17% |
Recent News & Updates
The Price Is Right For CLASSYS Inc. (KOSDAQ:214150)
Sep 22
CLASSYS (KOSDAQ:214150) Is Reinvesting At Lower Rates Of Return
Aug 24Is There An Opportunity With CLASSYS Inc.'s (KOSDAQ:214150) 38% Undervaluation?
Jul 24CLASSYS (KOSDAQ:214150) Seems To Use Debt Rather Sparingly
Jul 09Does CLASSYS (KOSDAQ:214150) Deserve A Spot On Your Watchlist?
May 24Recent updates
The Price Is Right For CLASSYS Inc. (KOSDAQ:214150)
Sep 22CLASSYS (KOSDAQ:214150) Is Reinvesting At Lower Rates Of Return
Aug 24Is There An Opportunity With CLASSYS Inc.'s (KOSDAQ:214150) 38% Undervaluation?
Jul 24CLASSYS (KOSDAQ:214150) Seems To Use Debt Rather Sparingly
Jul 09Does CLASSYS (KOSDAQ:214150) Deserve A Spot On Your Watchlist?
May 24There Are Reasons To Feel Uneasy About CLASSYS' (KOSDAQ:214150) Returns On Capital
May 03CLASSYS Inc.'s (KOSDAQ:214150) 29% Jump Shows Its Popularity With Investors
Feb 27We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt
Feb 07CLASSYS Inc.'s (KOSDAQ:214150) P/E Is Still On The Mark Following 26% Share Price Bounce
Jan 08CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 22% Below Their Intrinsic Value Estimate
Jan 06CLASSYS Inc.'s (KOSDAQ:214150) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors
Nov 14We Think CLASSYS (KOSDAQ:214150) Can Stay On Top Of Its Debt
Jun 08CLASSYS Inc.'s (KOSDAQ:214150) 27% Jump Shows Its Popularity With Investors
May 21Capital Investment Trends At CLASSYS (KOSDAQ:214150) Look Strong
Apr 24Here's Why I Think CLASSYS (KOSDAQ:214150) Is An Interesting Stock
Apr 09When Should You Buy CLASSYS Inc. (KOSDAQ:214150)?
Mar 09Is CLASSYS Inc.'s (KOSDAQ:214150) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 17CLASSYS Inc. (KOSDAQ:214150) Shares Could Be 29% Below Their Intrinsic Value Estimate
Feb 02
The Trend Of High Returns At CLASSYS (KOSDAQ:214150) Has Us Very Interested
Jan 17Here's Why I Think CLASSYS (KOSDAQ:214150) Might Deserve Your Attention Today
Jan 04The CLASSYS (KOSDAQ:214150) Share Price Has Gained 271%, So Why Not Pay It Some Attention?
Dec 22Is Now The Time To Look At Buying CLASSYS Inc. (KOSDAQ:214150)?
Dec 09What Type Of Shareholders Own The Most Number of CLASSYS Inc. (KOSDAQ:214150) Shares?
Nov 26Shareholder Returns
| A214150 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -1.9% | -3.2% | 2.0% |
| 1Y | -10.9% | -22.6% | 34.8% |
Return vs Industry: A214150 exceeded the KR Medical Equipment industry which returned -22.6% over the past year.
Return vs Market: A214150 underperformed the KR Market which returned 34.8% over the past year.
Price Volatility
| A214150 volatility | |
|---|---|
| A214150 Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in KR Market | 10.4% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A214150 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A214150's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 394 | n/a | classys.co.kr |
CLASSYS Inc. provides medical aesthetics devices worldwide. The company offers ULTRAFORMER MPT, a solution for eyebrow lifting; ULTRAFORMER III, an ultrasound surgical device used for tissue coagulation in eyelid lifting, and for skin tightening and improving subcutaneous tissue elasticity in the face (cheeks), abdomen, and thighs; VOLNEWMER, a monopolar radiofrequency therapeutic equipment used to coagulate skin tissue; Secret RF, a device that delivers radio frequency energy into the skin; Secret PRO, a multiple fractional device that delivers micro-level laser beams fractionally to the tissue; Secret DUO, a multi-functional device that delivers high-frequency energy through needle electrodes; and Fortra, a 4 wavelengths diode laser. It also provides SCIZER and CLATUU Alpha for non-invasive subcutaneous fat reduction; Ulfit, a medical device used to improve skin elasticity and subcutaneous tissue in the abdomen and thighs; Refit, a medical device that uses RF and negative pressure to increase tissue temperature and blood flow, relieving pain in the treated area; AQUAPURE, a combination of four handpieces used for acne suction, muscle pain relief, and other pain relief; FORSHAPE, an RF treatment system used to increase metabolism, blood circulation, and tissue recovery; and INTRASURE for lifting, wrinkle reduction, body contouring, and cellulite reduction.
CLASSYS Inc. Fundamentals Summary
| A214150 fundamental statistics | |
|---|---|
| Market cap | ₩3.23t |
| Earnings (TTM) | ₩101.49b |
| Revenue (TTM) | ₩294.21b |
Is A214150 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A214150 income statement (TTM) | |
|---|---|
| Revenue | ₩294.21b |
| Cost of Revenue | ₩65.86b |
| Gross Profit | ₩228.36b |
| Other Expenses | ₩126.87b |
| Earnings | ₩101.49b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.55k |
| Gross Margin | 77.62% |
| Net Profit Margin | 34.50% |
| Debt/Equity Ratio | 16.5% |
How did A214150 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 19:33 |
| End of Day Share Price | 2025/10/02 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CLASSYS Inc. is covered by 22 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Heejin Lim | Citigroup Inc |
| Dong Cheol Shin | CLSA |
| Sanjeev Rana | CLSA |